Associate Professor Giuseppe M. J. Barca from the University of Melbourne has led a team to achieve a historic milestone: the first quantum simulation of biological systems at a scale necessary to accurately model drug performance. Using the Frontier supercomputer at Oak Ridge National Laboratory in Tennessee, the team has developed software that can accurately predict the chemical reactions and physical properties of molecular systems, comprising of up to hundreds of thousands of atoms—delivering highly precise predictions of molecular behavior and setting a new benchmark in computational chemistry. This project, in collaboration with Oak Ridge National Laboratory, AMD, and deep-tech startup QDX, allows for unprecedented precision in simulating drug behaviour. “We can now observe not just the movement of a drug but also its quantum mechanical properties. This is vital for assessing drug viability and designing new treatments,” said Associate Professor Barca. This breakthrough is crucial as over 80% of disease-causing proteins remain untreatable with current drugs. By expanding our computational toolset, this technology promises faster, more accurate drug discovery and the potential for new treatments. Read more below about this advancement. https://lnkd.in/g3YZ46g2 #MetricBio #Recruitment #DrugDiscovery #FrontierSupercomputer #Innovation #MedicalResearch
About us
Utilizing our expertise to provide recruitment solutions to some of the worlds most cutting-edge companies in MedTech and Life Science. Our world-leading team of expert’s passion lies in deliver cutting edge talent solutions to visionary clients, positively impacting human health within a variety of specialisms including: - Biotech - CDMO - CRO - MedTech New York | London | Florida | Nottingham
- Website
-
http://www.metric-search.com
External link for Metric Bio
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- New York
- Type
- Privately Held
- Specialties
- Biotech , Genomics, Lab Automation, Cell & Gene Therapy, Cellular Agriculture, CDMO, Biologics, Drug Products, API, CRO, Pre-Clinical, Clinical, E-Clinical, Clinical Trial Supply, Drug Discovery, Digital Health, HealthTech, Artificial Intelligence, SaaS, Telemedicine, MedTech, Neurotech, FemTech, Cardiovascular, Medical Imagine & AI, Surgical Robotics, Orthopaedic and Spine, Pharma, and Molecular Diagnostics
Locations
-
Primary
New York, US
-
Fort Lauderdale, US
-
London, GB
-
Nottingham, GB
Employees at Metric Bio
Updates
-
Metric Bio is a hub for world-class talent acquisition specialists, dedicated to matching the right people with the best suited roles. Our team takes pride in building strong partnerships and delivering top talent solutions through our specialized industry knowledge. Cell and Gene CDMO specialist Sam McElroy exemplifies the exceptional talent we have at Metric Bio, consistently showcasing his expertize. Read below about Heather Sheely, SHRM-CP's experience with Sam McElroy and visit his webpage to learn how Sam can assist you with your hiring needs. https://lnkd.in/eAGh-U3z #MetricBio #Testimony #CDMO
-
Novo Holdings, a leading life science investor, has led a $105 million financing in Magenta Medical Ltd., developers of the Elevate System, the world’s smallest heart pump. This funding supports Magenta’s US clinical programs, targeting FDA approval for the Elevate System in patients undergoing high-risk percutaneous coronary interventions (HR-PCI). The Elevate System, designed for mechanical circulatory support (MCS), offers a minimally invasive solution for patients with severe cardiovascular conditions, earning FDA's Breakthrough Device Designation. Eric Snyder from Novo Holdings joins Magenta’s Board of Directors, expressing confidence in the technology's potential to transform patient care. Magenta Medical Ltd.'s CEO Dr. David Israeli welcomes this partnership, emphasizing the alignment with other top MedTech investors to advance their mission. With a pivotal US study on the horizon, Magenta is poised to make significant strides in the MCS field. Click the link below to learn more about the implications of this investment. https://lnkd.in/eaJWNQbz #MetricBio #MedicalInnovation #HeartHealth #MCS #MagentaMedical #NovoHoldings
Novo Holdings leads $105 million financing of Magenta Medical to support FDA approval for world’s smallest heart pump
novoholdings.dk
-
At Metric Bio, we pride ourselves on being a global brand. We offer career opportunities around the world with leading companies, providing you with a seamless career journey. Why not see for yourself? Explore some our current opportunities and visit our jobs page to learn more. https://lnkd.in/eWEBHaFG #MetricBio #CurrentRoles #Recruitment
-
-
Using his vast connections in the Drug Discovery and Development space, James Howsam truly finds the best fit for his clients, ensuring they get the most out of their partnership with Metric Bio. We’re not the only one who think so as Carol Gebert highlights the extraordinary opportunity that James was able to offer her. Read more below and visit James Howsam’s webpage to learn more about his impressive track record. https://lnkd.in/e7H_-zXJ #MetricBio #DrugDescovery #DrugDevelopment #Recruitment
-
-
Flagship Pioneering has secured an additional $3.6 billion in funding, increasing its total raised to $6.4 billion since 2021. This includes $2.6 billion for its eighth venture fund and $1 billion for strategic partnerships. This funding will support the creation of approximately 25 breakthrough companies in health, sustainability, and AI. With a portfolio featuring 40 companies, including Moderna, and a total capital pool of $10.9 billion, Flagship Pioneering continues to lead in biotech innovation. Read more about this funding below. https://lnkd.in/ebhjuzxK #FlagshipPioneering #Biotech #Innovation #VentureCapital #HealthTech
Flagship raises $3.6B for biotech investing
biopharmadive.com
-
There's been a lack of innovation in Exec Search - until now. Following meetings with our existing PE and VC partners, we're delighted to launch Metric Exec. With our own PE backing from BGF, we're ready to disrupt the market with our brand new service offering. Transparent. Tailored. Client-friendly. Check out the website for more info - https://lnkd.in/eHgNrYhN #execsearch #metric
-
At Metric Bio we truly value the partnerships we’ve developed with some of the most innovative and cutting-edge companies in the world. As part of our commitment to developing these relationships, team members such as James Barraclough routinely arrange face to face meetings with clients such as Boston Scientific. Read about James Barraclough’s experience visiting Boston Scientific and visit his web page to see even more of his impressive partnerships – https://lnkd.in/gvUSiq25 #MetricBio #Communication #Values
Back in NYC after a site visit to Boston Scientific's global headquarters in Marlborough. I had some great meetings about supporting future growth across the business and it was fantastic to meet with members of the team in person! Shoutout to Jorge Bains & Erin Carroll for looking after me! If you are looking for a recruitment partner you can trust or, are considering making a career change, I'd love to setup some time to meet. 📩
-
-
Supreme Court Decision Impacts FDA. The recent Supreme Court ruling to overturn the Chevron doctrine could significantly affect FDA regulations, including lab-developed tests (LDTs). The 6-3 decision means courts no longer defer to federal agencies on ambiguous statutes, with broad implications for all agencies. Jeff Gibbs from Hyman, Phelps & McNamara highlighted potential unforeseen effects, especially for the medical device industry. Despite this, the FDA remains confident in its legal foundations. Former FDA Commissioner Scott Gottlieb noted immediate impacts on LDT regulations, which recently shifted to stricter oversight due to growing risks associated with these tests. Read below to learn more about the implications of this change. https://lnkd.in/gDfXywXJ #MetricBio #SupremeCourt #FDA #ChevronDoctrine #LDTs #Regulation #MedTech
FDA’s lab developed test rule could be first check on agency’s power post-Chevron
medtechdive.com
-
Last week marked a pivotal milestone for Metric as we secured multi-million-pound investment from BGF. Following 5 years' of outperforming the market, this partnership will help further supercharge our growth, and is the culmination of everything we've been working towards with Metric 2.0. The deal also saw the introduction of Andy McRae as our new Non-Exec Chairman. Andy brings with him a wealth of experience and is a valuable addition to our team. In true Metric fashion, we're already looking ahead to what's next. If you want to be a part of something truly market-leading, drop us a message to learn more. https://lnkd.in/edprKiSa #metricbio #bgf #recruitment #investment #privateequity
Metric Search secures multi-million BGF investment to drive US growth - BGF
https://www.bgf.co.uk